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Abstract
Objective: MicroRNAs (miRNAs) are a class of non-coding RNAs (ncRNAs) that tran-
scriptionally or post-transcriptionally regulate gene expression through degradation of 
their mRNA targets and/or translational suppression. However, there are a few reports 
on miRNA-mediated expression regulation of long ncRNAs (lncRNAs). We have previ-
ously reported a significant upregulation of the lncRNA SOX2OT and its intronic cod-
ing gene, SOX2, in esophageal squamous cell carcinoma (ESCC) tissue samples. In 
this study, we aimed to evaluate the effect of induced overexpression of miR-211 on 
SOX2OT and SOX2 expression in vitro.
Materials and Methods: In this experimental study, we performed both bioinformatic 
and experimental analyses to examine whether these transcripts are regulated by 
miRNAs. From the list of potential candidate miRNAs, miR-211 was found to have 
complementary sequences to SOX2OT and SOX2 transcripts. To validate our finding 
experimentally, we transfected the NT-2 pluripotent cell line (an embryonal carcinoma 
stem cell) with an expression vector overexpressing miR-211. The expression chang-
es of miR-211, SOX2OT, and SOX2 were then quantified by a real-time polymerase 
chain reaction (RT-PCR) approach.       
Results: Compared with mock-transfected cells, overexpression of miR-211 caused a 
significant down-regulation of both genes (P<0.05). Furthermore, flow-cytometry analysis 
revealed a significant elevation in sub-G1 cell population following ectopic expression of 
miR-211 in NT-2 cells.                  
Conclusion: We report here, for the first time, the down-regulation of SOX2OT and 
SOX2 genes by an miRNA. Considering the vital role of SOX2OT and SOX2 genes in 
pluripotency and tumorigenesis, our data suggest an important and inhibitory role for 
miR-211 in the aforementioned processes.     
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Introduction
Long non-coding RNAs (lncRNAs) represent 
a large fraction of the human transcriptome, 
and are recently acknowledged as a new class 
of gene expression regulators (1, 2). These mol-
ecules are found to be involved in epigenetic 
events as well as in regulation of pluripotency 
and differentiation processes (3, 4). LncRNAs 
have been also implicated in tumorigenesis, 
with some classified as oncogenes or tumor-
suppressor genes (5). They have also been re-
ported to possess an enhancer-like function in 
human cells (6). The human genome contains 
thousands of lncRNAs that are expressed at low 
levels and in a tissue-specific manner. Com-
pared with protein-coding genes, lncRNAs are 
less conserved, and about a third of them are 
primate-specific (7). While the expression and 
function of small ncRNAs [e.g. microRNAs 
(miRNAs)] are widely studied, much less stud-
ies have been devoted to lncRNAs.
SOX2 gene, encoding a master regulator of 
pluripotency, lies within the third intron of a 
lncRNA, SOX2OT, which is transcribed in the 
same direction as SOX2. We recently reported 
that SOX2OT is upregulated along with master 
regulators of pluripotency, SOX2 and OCT4, in 
esophageal squamous cell carcinoma (ESCC). 
Moreover, the novel variants of SOX2OT 
(SOX2OT-S1 and SOX2OT-S2) showed distinct 
expression patterns and were downregulated 
during the process of neural differentiation of 
human embryonal carcinoma stem cells known 
as the NTERA-2/NT-2 cell line (8, 9).
miRNAs are a class of small (18-22 nt) ncR-
NAs that regulate gene expression mostly at the 
post-transcriptional level. They contribute to 
various cellular processes such as cell prolif-
eration, cell growth and development, cellular 
stress response and apoptosis (10). Alterations 
in the expression of miRNAs have been widely 
reported in numerous diseases including almost 
all types of cancers. Acting as oncogenes (on-
comiRs) or tumor suppressors, miRNAs play 
prominent roles in cancer-related processes 
such as proliferation, apoptosis, metastasis and 
angiogenesis (11). Due to their high stability 
and cell- and tissue-specific expression pat-
terns, miRNAs have received tremendous at-
tention as potential diagnostic, prognostic and 
therapeutic agents over the past decade (12).
mir-211 is mapped to a frequently altered lo-
cus in cancers on chromosome 15q13. Despite 
its hot spot location, the exact role of miR-
211 in carcinogenesis has not yet been clearly 
defined. We used bioinformatics approaches 
to find potential miRNAs capable of hitting 
SOX2OT and/or SOX2 transcripts. We then ex-
perimentally validated the down-regulation of 




In this experimental study, human embryonal 
carcinoma stem cells (NT-2), which highly ex-
press SOX2OT and SOX2 genes, were kindly pro-
vided by Dr. Peter W. Andrews at University of 
Sheffield, UK. Cells were cultured in Dulbecco’s 
Modified Eagle’s Medium (MDEM)/F12 medium 
(Invitrogen, USA) supplemented with 10% fetal 
bovine serum (FBS, Invitrogen, USA) and 100 
U/ml penicillin/streptomycin (Sigma, USA) and 
incubated in a humidified incubator in an atmos-
phere of 5% CO2 at 37˚C.
Bioinformatics analysis 
The bioinformatics tool miRcode (http://www.
mircode.org/mircode; miRcode 11, accessed June 
2012) was employed to find complementary se-
quences of miR-211 with SOX2OT and SOX2 
transcripts. miRcode is a comprehensive search 
tool for putative miRNA target sites across the 
complete GENCODE annotated transcriptome 
which includes 10,419 lncRNA genes in the cur-
rent version.
mir-211 cloning in an expression vector 
The recombinant expression plasmid pEGFP-C1 
containing the miR-211 precursor as well as the 
mock vector with no insert was purchased from 
ParsGenome Company (Tehran, Iran).  Both con-
structs contained Neomycin and GFP to enable se-
lection and detection of transfected cells.  PEGFP-
C1-miR-211 vector containing EcoR1 and BamHI 
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restriction sites on their respective 5´ and 3´ ends 
of mir-211 were used to amplify a 181 bp segment 
containing the pre-miR-211 sequence by specific 
primers (Table 1).  
Ectopic expression of miR-211 in NT-2 cells
The NT-2 cells were seeded at a concentration of 
4×104 cells per well in 12-well plates and incubat-
ed for 24 hours in culture medium. The cells were 
transfected with 1.5 µg of pEGFP-C1-miR-211 or 
mock vectors, using Lipofectamin 2000 reagent 
(Invitrogen, USA) and according to the manufac-
turer’s instructions.
RNA extraction
Cells were harvested 48 hours after transfec-
tion and total RNA was extracted from the cells 
using Trizol (Invitrogen, USA) according to the 
manufacturer’s instructions. The precipitated 
RNA was re-suspended in 20-30 µl RNase-free 
dH2O and was treated with DNaseI (Sigma, 
USA) to remove any potential trace of DNA con-
tamination. The quality and quantity of the total 
RNA were then determined using agarose gel 
electrophoresis and spectrophotometry (meas-
uring absorbance at 260 nm, NanoDrop2000c, 
Thermo Fisher Scientific Inc., Wilmington, DE, 
USA) respectively.
Synthesis of cDNA
The first strand of cDNA was synthesized by 
using a reverse transcriptase (RT, Takara, Japan), 
oligo-dT and random hexamer primers (Takara, 
Japan) according to the manufacturer’s instruc-
tions. For each sample, a no- RT control was 
used in parallel to the DNase-treated RNA, to 
detect any potential non-specific amplification 
of genomic DNA. Synthesis of cDNA for ex-
pression analysis of miR-211 was performed 
separately by a different procedure using a miR-
NA amplification kit (ParsGenome, Iran). This 
was carried out in three main steps including 
addition of polyA tail, specific cDNA synthesis, 
and real-time PCR amplification, according to 
the manufacturer’s instructions.
Table 1: Sequence of primers used for cloning and/or amplification of all genes
Sequence of primers  Genes
F: 5ˊCCGGAATTCCGGTTTTACAACACCCCATTTCACC 3ˊmiR-211 precursor 
R: 5ˊCGCGGATCCGCGCGAGCAACAGAGTAGAACAGG 3ˊ
F: 5ˊ AAGAGAACACCAATCCCATCC 3ˊSOX2a
R: 5ˊ TCCAGATCTATACAAGGTCCATTC 3ˊ
F: 5ˊ GATCACCTATTATAATTTTACC 3ˊSOX2OTb
R: 5ˊ GAAACCTGTCAGGCTTTCTTC 3ˊ
F: 5ˊ GCCACATCGCTCAGACAC 3ˊGAPDHc
R: 5ˊGGCAACAATATCCACTTTACCAG 3ˊ
a; SOX2, SRY (sex determining region Y)-box 2, b; SOX2OT, SOX2 overlapping transcript and c; GAPDH, Glyceraldehyde 
3-phosphate dehydrogenase. 
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Quantitative polymerase chain reaction 
(qRT-PCR)
Expression of mir-211, SOX2OT and SOX2 
were quantified in NT2 cells transfected with 
pEGFP-C1-miR-211 or pEGFP-C1-mock vec-
tors 48 hours after transfection, using ParsGe-
nome’s miRNA amplification Kit. All experi-
ments were performed at least in duplicate using 
a Bio-Rad thermal cycler (Hercules, USA) with 
the following conditions: 95˚C for 10 seconds, 
62˚C for 10 seconds, and 72˚C for 30 seconds. 
Melting curves were then determined with tem-
perature ranging 60 to 95˚C. miR-16 was cho -
sen as an internal control (13) for normaliza-
tion of miR-211 quantification. PCR efficiency 
for miR-211 and miR-16 was measured using 
standard curves generated by serial dilutions of 
generated cDNA.
Specific real-time PCR primers were also 
designed for SOX2OT, SOX2 and glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH, as 
an internal control) using AlleleID 6.0 (Primer 
BioSoft, USA) and Gene Runner (version 3.02, 
Hastings Software Inc.) softwares. Primer se-
quences for amplifying cDNA of SOX2, SOX2OT 
and GAPDH have been listed in table 1 (length 
of products: 162, 128 and 115 bp, respectively). 
TaKaRa SYBR Premix Ex Taq ІІ master mix 
(2X), supplemented with ROX reference Dye 
II, were used for all real-time PCR reactions. To 
compensate for variation in the amount of input 
RNA and the efficacy of reverse transcriptase, 
GAPDH mRNA was also quantified as an in-
ternal control, and related expressions of SOX2 
and SOX2OT were normalized to the expression 
value of the internal control.  All real-time PCR 
reactions were carried out by an ABI 7500 real-
time PCR instrument (Applied Biosystems, CA) 
using the following cycling conditions: initia-
tion at 94˚C for 1 minutes, amplification for 40 
cycles with denaturation at 94˚C for 10 seconds, 
annealing  at 62˚C for 10 seconds and extension 
at 72˚C for 40 seconds. The expression of the 
genes were defined based on the threshold cycle 
(Ct) and relative expression levels were deter-
mined as 2-[Ct of target gene)-(Ct of internal control)].
Cell cycle analysis by flow cytometry 
For cell cycle analysis, cells were collected 
48 hours after transfection with pEGFP-C1-
miR-211 or pEGFP-C1-mock vector. The cells 
were washed in phosphate bovine serum (PBS) 
and trypsinized with 0.025% trypsin-EDTA to 
yield single cell suspension. Cells  were then 
fixed in ice-cold 70% ethanol and stained with 
50 μg/ml propidium iodide (PI) solution con-
taining 10 μg/ml RNaseA (Takara, Japan) and 
0.1% Triton X-100. Two groups of cells were 
used for flow cytometric analysis using Attune 
Acoustic Focusing Cytometer (Applied Biosys-
tems, USA). Experiments were repeated at least 
twice and cell cycle profiles were analyzed us-
ing Flowing Software version 2.5.
Statistical analysis 
Data are presented as mean ± SD based on a 
minimum of three separate experiments. Signifi-
cance of differential expression was analyzed us-
ing the Student’s t test. Real-Time RT-PCR data 
were adjusted based on the exact PCR efficiency. 
SPSS software version 17.0 (SPSS, Inc., USA) 
was used for performing all the analyses. P<0.05 
was considered statistically significant.
Results
miR-211 has binding sites on SOX2OT and 
SOX2 transcripts
Bioinformatics analysis revealed a miR-211 pu-
tative target site (AGGGAG) on the third exon of 
SOX2OT at nucleotide position 659 (Fig.1). In-
terestingly, the same target site was also found on 
SOX2 gene.
Induced ectopic expression of miR-211 in NT2 
cells  
To experimentally validate the aforementioned 
bioinformatics results, we chose NT2 as a pluripo-
tent cell line previously shown by us (8) to higly 
express SOX2OT and SOX2. Accordingly, miR-
211 was cloned in a pEGFP-C1 plasmid and the 
resultant recombinant plasmid was then employed 
to transiently transfect NT-2 cells (Fig.2). The 
real-time PCR approach was then used to meas-
ure the level of miR-211 in NT2 cells transfected 
with pEGFP-C1-miR-211, in comparison with the 
pEGFP-C1-mock transfected cells as control. A 
significant upregulation was observed in the cells 
over-expressing miR-211 (15.5-fold), 48 hours af-
ter transfection (P<0.05).
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Fig.1: A schematic representation of the bioinformatics analysis on miR-211 potential targeting sites on SOX2OT and SOX2 transcripts. 
miR-211 has a putative target site on the third exon of SOX2OT, as well as similar target sites on the SOX2 transcript. The SOX2OT gene 
contains five exons where the intron-less gene SOX2 embedded within its third intron. Seed sequence of the mature form of miR-211 has 
been represented with red font.
Fig.2: A. Recombinant vector of pEGFP-C1 containing the precursor of miR-211, B. Verifying the accuracy of cloned miR-211 precursor 
within pEGFP-C1-miR-211 vector by restriction digestion and PCR analysis, lane 1: Double-digest of pEGFP-C1-miR-211 with EcoRI and 
BamHI produced a 181 bp segment corresponding to the miR-211 precursor insert and a 4731 bp linear vector, lane 2: A 181 bp PCR seg-
ment (bottom band) is amplified by specific primers, lane 3: A single digestion of pEGFP-C1-miR-211 by EcoRI produced a 4880 bp frag-
ment, lane 4: Single digestion of pEGFP-C1-mock digested with EcoRI produced a 4731 bp-fragment, lanes 5 and 6: 1 kb and 50 bp DNA 
ladders respectively, C. Phase contrast micrograph of NT-2 cells 48 hours after transfection with pEGFP-C1-miR-211 and D. Fluorescence 
micrograph showing transfected cells expressing GFP as a reporter. PCR; Polymerase chain reaction.
BA
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Over-expression of miR-211 caused down-regu-
lation of SOX2 and SOX2OT  
The relative expression level of SOX2 and 
SOX2OT was measured by real-time RT-PCR 
in cells transfected with pEGFP-C1-miR-211 
compared with control cells. As shown in 
figure 3, the expression of SOX2OT was sig-
nificantly diminished (27-fold) in cells over-
expressing miR-211. Similarly, a 9-fold down-
regulation of SOX2 was observed in the same 
cells transfected with pEGFP-C1-miR-211 
(P<0.05, Fig.3).
Effects of miR-211 over-expression on the cell 
cycle progression in NT-2 cells 
NT-2 cells were analyzed by flow cytometry cell 
cycle analysis 48 hours after transfection. An altered 
cell cycle distribution was observed in cells overex-
pressing mir-211 when compared with cells transfect-
ed with the pEGFP-C1-mock vector as control. miR-
211 caused a significant decrease in the percentage 
of cells in the S and G0/G1 phases of the cell cycle. 
Moreover, although a significant arrest at sub-G1 was 
observed in cells overexpressing miR-211, no signifi-
cant decrease in the percentage of the cells in G2/M 
phase was observed (Fig.4).
Fig.3: Relative expression of SOX2 and SOX2OT in NT-2 cells transfected with pEGFP-C1-miR-211 or pEGFP-C1-mock (control). Ectopic 
expression of miR-211 precursor reduced the level of SOX2 and SOX2OT transcripts in transfected cells drastically (P<0.05).
Fig.4: A, B. Flow cytometry data demonstrating altered cell cycle distribution of NT-2 cells following ectopic expression of miR-211 and 
C. Flow cytometry analysis of NT-2 cells 48 hours after transfection of cells with pEGFP-C1-miR-211 or pEGFP-C1-mock (control) revealed 
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Discussion
lncRNAs have been reported to play an important 
part in stem cell biology as well as in tumor initia-
tion and progression (14). SOX2OT, a dynamically 
regulated lncRNA, has conserved functions during 
vertebrate development. We recently had reported 
differential expression and alternative splicing of 
SOX2OT during neural differentiation of pluripo-
tent cells and esophagus tumorigenesis (8). Here, 
we expanded our previous findings by exploring a 
potential miRNA capable of regulating SOX2OT.
Transcription pattern of SOX2OT and SOX2 has 
been proposed to be regulated in the same manner 
as in pluripotent stem cells such as NT2 cells (8).  In 
this study, down-regulation of SOX2OT and SOX2 
have been demonstrated simultaneously with miR-
211 ectopic expression in NT2 cells. This finding is 
in agreement with the hypothesis proposed by Am-
aral et al. (9) and Shahryari et al. (8) on the possi-
ble role of SOX2OT in regulating SOX2 expression. 
Silencing SOX2OT by specific siRNAs as reported 
by Shahryari et al. demonstrated an inhibitory effect 
on SOX2 expression as well as an inductive one on 
subG1/G1 cell cycle arrest in NT2 cells (8).  
Moreover, our flow cytometry data on miR-211 
over-expressing cells is in agreement with two 
independent studies reporting that SOX2OT sup-
pression could attenuate S-phase entry and accu-
mulation of the cells in the G0/G1 cell cycle phase 
(15-17). Considering the nuclear localization of 
SOX2OT, it can be speculated that this lncRNA is 
acting at the transcriptional level rather than post-
transcriptional to regulate SOX2 expression (8). 
According to our data, miR-211 also contributes 
to this regulatory process probably via its capacity 
to alter gene expression at both transcriptional and 
post-transcriptional levels.
miR-211 is also thought to contribute to the 
cellular response to endoplasmic reticulum (ER) 
stress in a PKR-like endoplasmic reticulum kinase 
(PERK)-dependent fashion (17). This property of 
miR-211 may also be inferred from our current 
finding of significant accumulation of human NT2 
cells in the sub-G1 phase of cell cycle. PERK acti-
vation is related to the cellular inhibition of protein 
translation (18-20) with respect to miR-211 func-
tion. In addition, one study reported that a relevant 
target for miR-211 is the pro-apoptotic transcrip-
tion factor chop (17). Based on an unbiased bio-
informatics search, the chop gene promoter has 
two high-relevance complementary sequences 
matching the seed sequence of miR-211. In this 
model, miR-211 interacts directly with the chop 
promoter and confers its pro-survival influence by 
antagonizing pro-apoptotic chop expression. Thus, 
our bioinformatics data supports a model where-
in miR-211 functions in the context of ER stress 
signaling to regulate post-transcriptional gene si-
lencing via a chromatin-modification-dependent 
mechanism to moderate induction of pro-apoptotic 
chop and potentiate cell survival. Accordingly, the 
transient accumulation of miR-211 is reported to 
be necessary for temporal regulation of chop ex-
pression (17). Therefore, maintenance of miR-211 
would inhibit maximal accumulation of chop and 
this would inhibit the execution of damaged cells. 
However, validating this model requires further 
experimental confirmation.
miR-211 has also recently been implicated in neo-
plastic growth of colorectal tumors via regulation of 
the CHD5 tumor suppressor (21). This observation 
of potential oncomir activity of miR-211 is in con-
trast with our finding of a tumor suppressor role for 
miR-211 in esophagus cancer. These findings might 
support different tumor suppressive and oncomeric 
activities of miR-211 in different cancers.
Conclusion
We show that human miR-211 has a regulatory 
role on SOX2OT and SOX2 expression in NT2 
pluripotent cells. As SOX2OT and SOX2 have al-
ready been shown to contribute to tumorigenesis, 
miR-211 may also have a role but an inhibitory 
one in the same process.
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